An early glimpse at azacitidine plus venetoclax for myelodysplastic syndromes

Lancet Haematol. 2022 Oct;9(10):e714-e716. doi: 10.1016/S2352-3026(22)00252-6. Epub 2022 Sep 2.

¹ Austrian Group for Medical Tumor Therapy Study Group, Vienna, Austria; Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria; 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria. Electronic address: dr.lisa.pleyer@gmail.com.
² Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA.

No abstract available

Publication types